Physera is a company.
Physera has raised $11.0M across 2 funding rounds.
Key people at Physera.
Physera has raised $11.0M in total across 2 funding rounds.
Key people at Physera.
Physera has raised $11.0M in total across 2 funding rounds.
Physera has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in March 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2019 | $8.0M Series A | ||
| Nov 1, 2017 | $3.0M Seed |
Physera was a digital health startup launched in 2015 that provided virtual physical therapy for musculoskeletal (MSK) conditions, specializing in muscle and joint pain through telehealth video visits, in-app animations, voice prompts, and personalized digital exercise therapy.[1][2][3] It served employers and health plans by offering on-demand access to licensed physical therapists nationwide, aiming to reduce healthcare costs by preventing opioids, specialist visits, imaging, and surgery.[1][6] Physera solved the problem of limited access to MSK care with a clinically-focused, human-centered model that improved outcomes and lowered comorbidities, demonstrating early traction through partnerships like Activision Blizzard in 2019.[1][6]
In May 2020, Omada Health acquired Physera for a reported $30 million, integrating its MSK services into Omada's chronic care platform to create a comprehensive digital suite covering diabetes, hypertension, prevention, and MSK.[1][2][5][6] Post-acquisition, Physera's technology and Physical Therapy Group became core to Omada's offerings, earning URAC accreditation for MSK telehealth in 2023 and supporting growth with $192 million in funding.[4][5]
Physera emerged in 2015 amid rising demand for virtual MSK care, founded to modernize treatment through direct access to top providers and personalized digital interventions.[1][3] Led by CEO Dan Rubinstein, the company built a coast-to-coast network of licensed physical therapists empowered by technology for on-demand diagnosis and care plans.[2][7] Early traction came from employer partnerships, such as Activision Blizzard in 2019, where claims data showed cost savings for participants.[6] The pivotal moment arrived in 2020 when Omada Health, a 2011-founded pioneer in virtual chronic disease management, acquired Physera to expand into MSK, aligning with Omada's "digital care made human" philosophy.[1][2][5]
This acquisition blended Physera's expertise with Omada's evidence-based programs, fueling innovations like computer vision for remote movement assessment.[5]
Physera rode the telehealth boom for MSK care, accelerated by pandemic-driven demand for accessible, virtual-first solutions amid clinician shortages and rising chronic pain prevalence.[1][2] Timing was ideal as employers sought integrated digital health to cut costs on comorbidities like opioids and surgery, aligning with shifts toward value-based care.[1][6] Market forces favoring Physera/Omada include evidence-based virtual programs gaining accreditations (e.g., NCQA, URAC) and funding surges, like Omada's $192M round and $57M growth capital.[4][5] It influenced the ecosystem by pioneering hybrid PT models, now standard in digital health platforms, enabling scalable chronic care and setting benchmarks for human-centered telehealth.[2][5]
Post-acquisition, Physera's legacy powers Omada's MSK expansion, with innovations like AI-driven movement tracking positioning it for broader chronic care dominance.[5] Trends like whole-person virtual health, regulatory support for telehealth, and employer prioritization of MSK will shape growth, potentially through further integrations or partnerships.[2][4] Omada's influence may evolve into a one-stop chronic disease platform, bending health curves as employers demand comprehensive, cost-effective solutions—echoing Physera's original vision of accessible, human-led recovery at scale.[2][6]